These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1658753)

  • 1. [Proline hydroxylase (hPH) as marker of hepatic fibrosis in beta thalassemia].
    Leonardi S; Avola E; Rapisarda R; La Delfa W; Musumeci S
    Pediatr Med Chir; 1991; 13(3):267-9. PubMed ID: 1658753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease.
    Leonardi S; La Spina M; La Rosa M; Schilirò G
    Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
    Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
    Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
    J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human prolyl-hydroxylase: only a marker of hepatic damage?
    Tamaro G; Pozzato G; Moretti M
    Int J Clin Lab Res; 1993; 23(4):228. PubMed ID: 8123880
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study.
    Ardalan FA; Osquei MR; Toosi MN; Irvanloo G
    BMC Gastroenterol; 2004 Aug; 4():17. PubMed ID: 15307893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
    Bolarin D; Andy JJ; Alabi ZO
    Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of laminin and beta-subunit of prolyl 4-hydroxylase in the sera of human subjects with Schistosomiasis mansoni.
    Tanabe M; Sekiguchi T; Kaneko N; Kobayashi S; Takeuchi T; Coutinho A; Tateno S; Maruyama K; Okazaki I
    Jpn J Exp Med; 1989 Jun; 59(3):109-19. PubMed ID: 2554032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with chronic endomyocardial fibrosis.
    Bolarin DM; Andy JJ
    Ann Clin Res; 1983 Jun; 15(3):123-7. PubMed ID: 6314867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum enzymes of collagen synthesis and type III procollagen amino-propeptide in Nigerian patients with sickle cell disease.
    Bolarin M
    J Clin Chem Clin Biochem; 1986 Jul; 24(7):433-6. PubMed ID: 3016143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity diagnosis of liver fibrosis and liver cirrhosis].
    Langness U
    Med Klin; 1977 Mar; 72(12):492-6. PubMed ID: 190524
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver iron overload and liver fibrosis in thalassemia.
    Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P
    Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556
    [No Abstract]   [Full Text] [Related]  

  • 18. Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
    Kołtan S; Wysocki M; Kołtan A; Swiatkiewicz V; Styczyński J; Debski R; Balcar-Boroń A
    Med Sci Monit; 2002 Apr; 8(4):CR274-9. PubMed ID: 11951070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic prolyl hydroxylase activity in human liver disease.
    McPhie JL
    Hepatogastroenterology; 1980 Aug; 27(4):277-82. PubMed ID: 6259037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection.
    Mowla A; Karimi M; Afrasiabi A; De Sanctis V
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.